Latuda Tablet, Film Coated
Product Images NDC 63402-312

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Latuda (NDC 63402-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sumitomo Pharma America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lat01 0037 01

Chemical structure of lurasidone hydrochloride, the active ingredient in Latuda, a prescription drug in film-coated tablet form by Sumitomo Pharma America, Inc. The diagram depicts molecular rings and bonds characteristic of lurasidone hydrochloride with the hydrochloride (HCl) component indicated.*

FDA Label Image

Lat01 0037 02

A pharmacokinetic graph showing the fold change and 90% confidence interval for Cmax and AUC of lurasidone when administered alone versus with interacting drugs. The graph compares effects of strong CYP3A4 inhibitors (ketoconazole 400 mg/day), moderate CYP3A4 inhibitors (diltiazem 240 mg/day), and strong CYP3A4 inducers (rifampin 600 mg/day, lithium 600 mg BID) on lurasidone's pharmacokinetic parameters.*

FDA Label Image

Lat01 0037 03

A forest plot chart depicting the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, or trough) of various interacting drugs including Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium 600 mg BID. The x-axis shows the change relative to the interacting drug alone, ranging from -1.0 to 1.0.*

FDA Label Image

Lat01 0037 04

A pharmacokinetic (PK) fold change chart with 90% confidence intervals showing changes in Cmax and AUC relative to reference for Latuda (lurasidone hydrochloride) in populations with renal and hepatic impairment of varying severity, and population subgroups by gender, race, and Asian ethnicity. The x-axis represents change relative to reference, with data points and error bars for each category.*

FDA Label Image

Lat01 0037 05

Latuda 20 mg film-coated oral tablets label displaying the proprietary name Latuda and generic name lurasidone HCl. The label indicates 30 tablets per container and includes instructions for dispensers to provide the Medication Guide. It shows manufacturer Sunovion Pharmaceuticals Inc. with storage instructions and a barcode. Dosage and packaging details are also present along with a QR code and lot information on the side.*

FDA Label Image

Lat01 0037 06

Latuda 40 mg film-coated tablets label showing the brand name, generic name lurasidone HCl, package size of 30 tablets, and drug information including strength and storage instructions. The label includes barcodes, a dispenser notice, manufacturer details (Sunovion Pharmaceuticals Inc for Sumitomo Pharma America, Inc), and a Data Matrix barcode with GTIN, SN, EXP, and LOT information.*

FDA Label Image

Lat01 0037 07

Latuda 60 mg film-coated tablets label showing the proprietary name, generic name (lurasidone HCl), dosage strength, and quantity of 30 tablets. The label includes dispensing and storage instructions, manufacturer information (Sunovion Pharmaceuticals Inc.), and a barcode with an NDC number 63402-306-30. The label also displays a pink boxed section with encoded product identification details.*

FDA Label Image

Lat01 0037 08

Label for Latuda 60 mg film-coated tablets containing lurasidone hydrochloride. The label indicates a quantity of 90 tablets and includes storage instructions to keep at 25°C (77°F) with allowable excursions. The manufacturer is Sunovion Pharmaceuticals Inc., and the label advises dispensers to provide a medication guide with each dispensing.*

FDA Label Image

Lat01 0037 09

Latuda 60 mg (lurasidone hydrochloride) film-coated tablets label showing a white background with black and green text. The label indicates a 500 tablet count, Rx only, and is manufactured for Sunovion Pharmaceuticals Inc. Storage instructions and dispenser warnings are included. The label also features the Sunovion logo in green at the bottom.*

FDA Label Image

Lat01 0037 10

Latuda 60 mg tablets packaging label for oral use, containing 7 film-coated tablets of lurasidone hydrochloride. The label shows the product name, strength, count, and manufacturer Sunovion Pharmaceuticals. It includes tablet identification "L 60," dosage instructions, storage conditions, and a 7-day supply blister pack layout marked by days.*

FDA Label Image

Lat01 0037 11

Latuda 60 mg film-coated tablets carton label for oral use, containing 28 tablets (4 cards with 7 tablets each). The product contains lurasidone hydrochloride and is labeled for prescription-only use. Manufactured for Sunovion Pharmaceuticals Inc., the packaging includes dosage and storage information along with warnings and a barcode.*

FDA Label Image

Lat01 0037 12

A sheet of multiple drug product labels for Latuda 60 mg tablets, film-coated, containing lurasidone hydrochloride. Each label includes the product name, strength, dosage form, a barcode, the identifier 901749R00, and fields for expiration date and lot number. The labeler is listed as Sunovion Pharmaceuticals Inc.*

FDA Label Image

Lat01 0037 13

Packaging label for Latuda 60 mg film-coated tablets containing lurasidone hydrochloride, manufactured by Sunovion Pharmaceuticals Inc. The label shows a 100-tablet carton offering (10 cards, 10 tablets each) and includes dosage instructions, storage conditions, and safety warnings. The label displays the NDC 63402-306-10 and highlights that the medication is Rx only.*

FDA Label Image

Lat01 0037 14

Latuda (lurasidone HCl) tablets 80 mg film-coated, oral dosage form, labeled for 30 tablets per bottle. The label includes storage instructions to keep at 25°C (77°F) with permitted excursions between 15-30°C (59-86°F). Manufactured for Sunovion Pharmaceuticals Inc., Marlborough MA, made in Japan. NDC 63402-308-30 is visible, along with a dispenser notice directing users to a medication guide and contact information.*

FDA Label Image

Lat01 0037 15

Label for Latuda 120 mg (lurasidone HCl) film-coated tablets, packaged as 30 tablets. The label includes dispensing instructions, storage conditions, manufacturer information for Sunovion Pharmaceuticals Inc., and a machine-readable barcode. The product is made in Japan and labeled for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.